EUVIMEDEUVIMED entdecken
Open Access

Quercetin suppresses cell viability in triple-negative breast cancer by targeting ORM2

Xianhua Liu, Zhijun Chen

American Journal of Cancer Research · 2024 · 14 (11) · 5269-5285

DOI: 10.62347/depw1251 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Cancer Research, 2024. Verfasst von Xianhua Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian M…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

ORM2Triple-negative breast canceramino acid exchange validationdockingquercetin

Autor:innen und Institutionen

  • Department of Pathology, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University Fuzhou 350001, Fujian, China.
  • Department of Nuclear Medicine, The Second Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China.

Zitieren

APA

Liu, X., & Chen, Z. (2024). Quercetin suppresses cell viability in triple-negative breast cancer by targeting ORM2. American Journal of Cancer Research, 14(11), 5269-5285. https://doi.org/10.62347/depw1251

Vancouver

Liu X, Chen Z. Quercetin suppresses cell viability in triple-negative breast cancer by targeting ORM2. American Journal of Cancer Research. 2024;14(11):5269-5285. doi:10.62347/depw1251

BibTeX
@article{Liu2024,
  author = {Liu, Xianhua and Chen, Zhijun},
  title = {Quercetin suppresses cell viability in triple-negative breast cancer by targeting ORM2},
  journal = {American Journal of Cancer Research},
  year = {2024},
  volume = {14},
  number = {11},
  pages = {5269--5285},
  doi = {10.62347/depw1251}
}
Kostenlos starten →